LAS VEGAS, March 9, 2026 /PRNewswire/ — Certilytics, Inc., a leader in AI-driven healthcare intelligence solutions, today announced the commercial availability of Certilytics Health Language Model (CertHLM). This agentic, AI-powered interface delivers real-time data intelligence and expert decision support to health organizations. Leveraging Certilytics foundational data and predictive analytics solutions developed for and trusted by healthcare organizations over the last twelve years, CertHLM accelerates the analytics process to provide faster answers and insights for strategic decision-making.
“Across the healthcare industry, organizations aren’t struggling with a lack of data—they’re struggling with a lack of time and expert capacity to turn that data into action,” says Andrew Ottum, executive vice president at Certilytics. “CertHLM removes this bottleneck by transforming natural language questions into instant, expert-grade answers, delivering intelligence that would otherwise require hours of specialized analytical work.”
Certilytics will debut the technology during HIMSS 2026 in Las Vegas, where attendees can view live demonstrations at Booth 6244.
“Healthcare demands more than access to a powerful model; it demands governance, security, and operational trust,” said Elton Tavenner, executive vice president and chief technology officer. “CertHLM was built from the ground up as an enterprise-grade agentic platform, enabling healthcare organizations to deploy generative intelligence safely within their workflows, with controls and rigor that match the complexity of clinical and financial decision-making.”
CertHLM Performance and Integration Insights:
Alyssa Read VP of Marketing & Communications
Tel: 518-569-0600
Email: [email protected] SOURCE Certilytics
- Purpose-built agentic framework using enriched healthcare data and predictive analytic outputs.
- Eliminates manual query-building and dashboard navigation by converting natural language queries into instant, expert-grade answers and reports.
- Accelerates the identification of emerging clinical risks, intervention opportunities, population program shifts and competitive service-line insights for leadership teams.
Alyssa Read VP of Marketing & Communications
Tel: 518-569-0600
Email: [email protected] SOURCE Certilytics
Source link
Leave a Reply